Eight dead in explosion at Shanxi Biotech facility, triggers investigation
West Bengal govt employees rally, demand immediate release of DA arrears
Rekha Gupta-led Delhi govt adds 500 new electric buses, city now has largest fleet in country
Surajkund swing collapse: Ride operator and staffer arrested after accident kills cop
Triple suicide case: Grandfather of Ghaziabad sisters urge government to ban Korean game
INDIA
)
SEC gave nod to Bharat Biotech's Covaxin for phase 2 and 3 human clinical trials on 2 to 18 years.